Clinical trial
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
NCT00002578 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00002578 |
|---|---|
| Title | Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma |
| Official title | Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | cytarabine, gallium nitrate, leucovorin calcium, methotrexate |
| Enrollment | 35 |
| Start date | Aug 1, 1994 |
| Primary completion | Jan 1, 2007 |
| First posted | May 20, 2004 |
| Last update posted | Oct 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: